ArticleSuccess For Sanofi And RouseWell known life sciences company, Sanofi and it's Chinese brand name ‘赛诺菲' are highly regarded in the Chinese market.ChinaIntellectual PropertyRouse
ArticleCrossing BordersPartner Janet Xiao, who leads the firm's China Life Sciences Group, co-authored an article with associate Can Cui for Intellectual Property Magazine, ...GlobalFood, Drugs, Healthcare, Life SciencesMorrison Foerster
ArticleChina Releases Vaccine Good Clinical PracticesOn October 31, 2013, The China Food and Drug Administration ("CFDA") promulgated a regulation titled Guiding Principles for the Quality Management of Clinical Studies on Vaccines ("Vaccine GCP"), with immediate effect. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
Article중국쓰쵠성,지식재산권 서비스거점 20개 구축을 통한 기업 지원 강화쓰촨성이 중점 산업단지와 지역에 20개의 지식재산 서비스거점을 구축하여 기업 맞춤형 공공서비스를 확대하고 있다. 루저우시를 중심으로 백주, 의약건,ChinaIntellectual PropertyKangxin
ArticleChina Announces Amendments to Regulation on the Supervision and Administration of Medical DevicesOn May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Solicits Comments On Biosimilars GuidelineThe Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChinese FDA To Launch A Quality Consistency Evaluation For Generic DrugsChinese State Food and Drug Administration ("SFDA") issued a draft Work Plan for Quality Consistency Evaluation for Generic Drugs ("Work Plan") on November 22 for public comments through December 6. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina’s New Rules on Compulsory Licensing of Patents for Public HealthOn 29 November 2005, the State Intellectual Property Office ("SIPO") of China issued the Measures for Compulsory Licensing of Patents Concerning Public Health ("Measures").ChinaIntellectual PropertyLovells
Article글로벌 바이오의약 산업 특허출원 순위 TOP100 발표2024년 10월 8일, 중국 특허 전문매체인 IPR Daily는 ‘글로벌 바이오의약 산업 특허출원 순위 TOP100'을 발표함...ChinaIntellectual PropertyKangxin
ArticleChina FDA's Pharmaceutical Regulations Ready for Public CommentsThe China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Unveils Detailed Rules to Implement The Core Device RegulationThe amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleBeijing IP Court Hears China's First Patent Linkage CasePatent linkage refers to the relationship between the market approval for a generic drug and the patent status of its branded equivalent.ChinaIntellectual PropertyRouse
ArticleWIPO世界知的財産グローバル賞、中国企業6社が最終候補入り世界知的所有権機関(WIPO)が2026年のWIPOグローバルアワードの最終候補33社を発表し、中国企業6社が選出されて国別で最多となった。環境、健康、情&ChinaIntellectual PropertyKangxin
ArticleChina's State Council Announces Major Policies to Reform the Pharmaceutical IndustryChina will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13"). ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Announces New Initiatives To Level The Playing Field For Innovative And Generic DrugsChina's Government will launch several incentives to enhance accessibility of innovative drugs, especially imported oncology drugs. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Issues Draft Guidance On Multi-Regional Clinical TrialsOn November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleLifesciences - A Legal guide to China (2nd edition)The CMS, China lifesciences team would like to introduce the 2nd edition of its legal guide to China, a 130 page guide to the lifesciences industry in China fully updated. ChinaFood, Drugs, Healthcare, Life SciencesCMS Cameron McKenna Nabarro Olswang
ArticleSFDA Requirement For Generic Pharmaceutical Re-EvaluationChina has become the world’s largest market for generic pharmaceuticals. Generics account for more than 90% of China’s total pharmaceutical market.ChinaFood, Drugs, Healthcare, Life SciencesClyde & Co